Function-Based Elopement Treatment for Autism

((FBET) Trial)

This trial explores a new approach to help children with autism who often wander off, a behavior known as "elopement." The treatment, Function-Based Elopement Treatment (FBET), aims to determine its ease of use in community clinics and its effectiveness in managing this behavior compared to usual treatments. Initially, the study will test FBET in one clinic and then compare it to regular treatment across several clinics. It is suitable for children aged 4-12 with autism who have been frequently wandering off for at least three months. As an unphased trial, this study provides families with a unique opportunity to contribute to pioneering research that could lead to more effective community-based treatments for autism-related elopement.

The trial information does not specify whether participants need to stop taking their current medications.

Previous studies found the Function-Based Elopement Treatment (FBET) for children with autism to be safe. Trials reported no major negative side effects, meaning participants did not experience serious problems from the treatment. Only a small number, 5.26%, left the study early, suggesting most participants felt comfortable continuing. Overall, FBET appears well-tolerated based on data from these studies.¹²³⁴⁵

Researchers are excited about the Function-Based Elopement Treatment (FBET) for autism because it offers a personalized approach, unlike typical behavioral interventions. While standard treatments often apply general strategies to manage elopement, FBET specifically addresses the underlying reasons why an individual might wander, tailoring interventions to each person's unique triggers and needs. This targeted approach aims to provide more effective and sustainable results in reducing elopement behaviors, offering a promising alternative to the more generalized methods currently in use.

Research has shown that Function-Based Elopement Treatment (FBET), which participants in this trial may receive, can help reduce the tendency of children with autism to run away or wander off. One study demonstrated that the benefits of FBET lasted for 28 weeks after treatment ended, indicating both short-term and lasting effects. Another study found that treatments tailored to the child's specific needs effectively reduced these behaviors. Additionally, a review of 17 treatments for 14 children supported the effectiveness of FBET. Importantly, no major side effects were associated with the treatment, making it a promising option for managing this behavior in children with autism.¹²⁶⁷⁸